SynthesisMedicine2015

Oxaliplatin-Based Doublets Versus Cisplatin or Carboplatin-Based Doublets in the First-Line Treatment of Advanced Nonsmall Cell Lung Cancer.

Jing Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.